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Asymmetric synthesis of a-arylpropionic acids, Ibuprofen lb, Naproxen Ic, and F1urbiprofen ld have been achieved by
employing Sharpless asymmetric dihydroxylation followed by the stereoseIective hydrogenolysis of the chiral dials
coupled with Jones' oxidation as the key steps. The regio- and stereoselective hydrogenolysis of the chiral diols at the
benzylic position proceeds with retention of configuration for all the substrates studied.
a-Arylpropionic acids ("profens") such as Ibuprofen lb,
Naproxen Ic, Flurbiprofen ld etc. (Figure 1) have
emerged as an important class of non-steroidal anti-
inflammatory drugs (NSAID) having analgesic and
antirheumatic properties. 1 Until now all profens except
Naproxen are administered as racemic mixtures although
the (S)-enantiomer displays the desired mode of function
by inhibition of prostaglandin biosynthesis.' The use of
racemate is justified to some extent since most (R)-
antipodes have been found to undergo an enzymatically
controlled in vivo racemization, the occurrence and
mechanism of which are well documented." However, it
is indispensible to realize the specificity of the required
(Sj-isomer and the toxicity and unnecessary load on the
metabolite by the undesired (R)-isomer which is revealed
by chemotherapeutic studies.' Thus optically active (5)-
isomer is highly desirable. Moreover, presently much
attention" is being paid to the problem of the
manufacture of non-racemic chiral drugs.
Asymmetric synthesis of these molecules by chemical
methods are still lacking efficient strategies and efforts
to make enantiomerically pure molecule are in progress.
Several methods' using classical resolution, enzymatic
reaction and a few chemical syntheses are reported in the
literature for the synthesis of these molecules. However,
some of the methods are having drawbacks such as
expensive reagents, low yield and optical purity, high
pressure reactions etc.
Hence we sought to find synthetic methodology which
would provide a general method to introduce the
stereo genic center common to all of the NSAID's. We
have developed a strategy whereby asymmetry is
introduced into the molecule by means of Sharpless
asymmetric dihydroxylation ' (AD) and then the required
stereogenic center is put in place by means of a highly
regio- and stereospecific hydrogenolysis of the benzylic
hydroxyl group with the retention of confi-guration
followed by the Jones' oxidation (Scheme I).
We wanted to check the validity of our strategy first
with an asymmetric synthesis of phenylpropionic acid
la. Then, having established the validity of the route, we
turned our attention to the application of this strategy to
the synthesis of representative members of this class of
drugs.
VCO~ UCO~~~CO~ 0
la ~ <;»: Ib Ic
co-a
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a: AI = Phenyl
b: AI = 4-Isobutylbenzene
c: AI = 6-Methoxynaphthalene
d: AI = 2-F1uorobiphenyl
Reagents: (i) AD mix-B. 28 hr; (ii) 10% Pd-C, HCOONH4, ethanol, reflux, 6h; (iii) Jones' reagent, 8 hr
Scheme I
When this work- was in progress Hamon and coo.
workers published" their work wherein the. diol 3 was in
turn converted to its epoxide and then the stereoselective
hydrogenolysis of the benzylic epoxide bond produced
the required stereo genic center.
Results and Discussion
For a model study, the synthesis of la was carried out
using a-methyl styrene 2a (Aldrich, USA) as starting
olefin. The optical purity of the final product 2-phenyl
propanoic acid la was found to be 60% ([a]o = 48.4;
c I, EtOH). For the construction of a range of
arylpropionic acids it was deemed desirable to develop
the key intermediate olefins 2b-d. The substituted
aromatics 5b,c were subjected to Friedel-Craft's
acylation to get the corresponding acetophenones 6b,c in
good yield (80-95%). These compounds were converted
to the corresponding tertiary alcohols 7b,c by treating
with methylmagnesium iodide. Here again the yields
were good. Compounds 7b,c had to be converted to the
respective olefins. Among the various methods tried
POClipyridine was found to be quite efficient (90%
yield) for dehydration (Scheme II). Having completed
the synthesis of key intermediates 2b,c, we planned for
the synthesis of various arylpropanoic acids.
(a) Asymmetric synthesis of Ibuprofen and Naproxen
The olefins 2b (m.p. 110 DC, yellow solid) and 5c
(m.p. 109-110 DC, yellow solid) were subjected to
Sharpless asymmetric dihydroxylation using (DHQDh-
PHAL as chiral auxiliary to furnish 85% of the diol 3b
[m.p. 67-70°C, [a]o -7.01 (c 1.0, EtOH)] and 3c [m.p.
119-122 DC, [a]o -8.14 (c 1.15, EtOH)] with 75% ee.
The ee of 3b was determined by use of chiral shift
(l)
Ar-H + AcC) -'-'--~~
80-95 %
5(b,c) 6(b,c)
b: AI = 4-Isobutylbenzene
c: Ar = 6-Methoxynaphthalene
reagent Eu(hfch_on. the .derived acetate whereas that of
3c was determined by comparing [a]o value with the
reported value.'
Hydrogenolysis of chiral benzylic alcohols with
Raney Ni and Pd-C have been known to proceed with
retention of configuration." Thus, the diols 3b and 3c
when subjected to hydrogenolysis over Pd-C in boiling
absolute ethanol using HCOON~ as hydrogen source
yielded 4b and 4c in 65% and 75% respectively with the
retention of configuration (65% ee in each case). Here
also the ee was calculated by complexing the derived
acetate with the chiral shift reagent, Eu(hfc)J. Mention
must be made here that in Hamon's case" there was an
inversion of configuration during the hydrogenolysis of
the benzylic epoxide bond.
The alcohol 4b [m.p. 101-103 DC, [a]o +8.4 (c 1.15,
EtOH)] and 4c [m.p. 85-87 DC, [a]o +2.2 (c 1.10,
EtOH)] was subjected to Jones' oxidation using freshly
prepared Jones' reagent" to get optically active a-
arylpropionic acid Ib [m.p. 54-56 ° C, [a]o +38 (c 1.40,
CHCIJ)] and Ic [ m.p. 154°C, [a]o +41.8 (c 1.0.
CHCIJ)] in 40% and 35% yield respectively (65% ee in
each case). The ee of the arylpropionic acid was low.
The low optical purity of the final product could be
because of partial racemisation during hydrogenolysis or
during the strongly acidic Jones' oxidation.
b) Asymmetric synthesis of Flurbiprofen
(S)-Flurbiprofen Id has received a significant interest
in recent years due to the profound and unexpected
effects on the activities by the introduction of fluorine. to
And also the ability of fluorine to mimic hydroxy












Reagents: (i) AlCI3, CH2Ch, (80-95%); (ii) MeMgI, ether, O°C,(90-95 %); (iii) POCI3, Pyridine (90%)
Scheme II
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exert profound pharmacological effects in improving the lysis at the benzylic position as key steps. The chemical
activity and selectivity of bioactive compounds and steps involved are efficient, easy to operate, economical
drugs." Here we also describe the synthesis of (S)-( +)- and industrially useful.
flurbiprofen 1d via AD reaction and selective Experimental Section
hydrogenolysis of the chiral diol under transfer All melting points are uncorrected. IR spectra were
hydrogenation conditions as key steps starting from recorded on Perkin-Elmer spectrophotometer model
racemic flurbiprofen 8 (Scheme ill). 683B or 1605 Fr-IR, IH and \3C NMR spectra in CDCh
The key intermediate 12 was obtained from racemic with tetramethylsilane as internal standard on either Ff'-
flurbiprofen. The racemic flurbiprofen!' was esterified' 80A, Bruker WH-90 or Bruker AC-200 instruments and
with thionyl chloride and ethanol in quantitative yield to mass spectra recorded on Finnigan MAT-I020-B-70 eV
9. The ester was reduced by LAH to furnish the alcohol mass spectrometer. All optical rotations were measured
10 (m.p. 56-58°C, 78% yield). The alcohol 10 was using Sodium D line on JASCO-181 digital polarimeter
tosylated to get 11 (m.p. 108-112 "C) by tosyl chloride at room temperature. All solvents were distilled before
in pyridine followed by LAH reduction to afford the use. Anhydrous Et20 and THF were distilled from
isopropyl derivative 12 in 72% yield. The isopropyl Nalbenzophenone.
derivative 12 was subjected to benzylic bromination to Preparation of 4-isobutylacetophenone 6b and 2-
give the bromocompound 13 in 84% yield. It was Acetyl-6-methoxynaphthalene 6c. To a stirred solution
dehydrobrominated using Lilsr and LhC03 as base in of either isobutylbenzene Sb or 6-methoxy-naphthalene
DMF to obtain 2-(2-fluoro-4-biphenyl)prop-l-ene 14 Sc (0.01 mole) and anhyd. AICh (2 g, 0.015 mole) in dry
(rn.p. 60-64 "C) in 65% yield. CH2Ch (100 mL), acetyl chloride (1.1 mL, 0.01
The olefin 14 was dihydroxylated using a AD mix-B mole)was added dropwise. The reaction mixture was
to furnish the diol 15 [m.p. 96-99 DC, [a]D -6.6 (c 1.5, stirred for 12 hr at 25°C and decomposed with ice-cold
EtOH)] with good enantiomeric excess (85% ee). The 6 water and dil. HCI. It was then extracted with CH2Ch,
diol1S was subjected to hydrogenolysis as in the case of washed with brine and dried over anhyd. Na2S04.
3b,c to give the alcohol 16 [m.p. 55-58°C, [a]o +8.4 (c Removal of solvent under reduced pressure gave the
1.1, EtOH), 74% yield] in 65% ee. The ee was corresponding ketone 6b and 6c which was further
determined by complexing the derived acetate with purified by column chromatography ( 2% ethyl acetate in
chiral shift reagent, Eu(hfch· The alcohol 16 was pet. ether). 6b: lightyellow solid; m.p. 99-100 DC, yield
oxidized to optically active a-arylpropionic acid ld by 95%; IR (Nujol): 1750, 1690, 1460, 1330, 1180, 1020
Jones' reagent in 72% yield and 57% ee. ern"; IH NMR (200 MHz, CDCI3): 8 0.9 (d, 1=7Hz,
In conclusion, the asymmetric synthesis of n-arylpro- 6H), 1.75 (m, l H), 2.55 (d, 1= 4Hz, IH), 2.60 (s, IH),
pionic acids, Ibuprofen 1b, Naproxen Ic, Flurbiprofen 7.2 (d, 1= 7Hz, 2H), 7.95 (d, 1=6.2Hz, 2H); 6c: b.p.
Id, was achieved by employing Sharpless asymmetric 230-235°C, yield: 88%; IR (Neat) 1760, 1685, 1610,











Reagents: (i) SOCI2, EtOH; (ii) LAH, THF; (iii) TsCl, Et3N; (iv) LAH, THF; (v) NBS, CCI4; (vi) LiBr, Li2C03, DMF;
(vii) AD mix-B: (viii) Pd-C, HCOONH4• ethanol; (ix) Jones' oxidation
Scheme III
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2.7 (s, 3H), 3.95 (s, 3H), 7.2 (m, 2H), 7.8 (m, 2H), 8.1
(d, J= 7Hz, IH), 8.45 (s, lH).
Peparation of alcohols 7b and 7c.To a solution of
freshly prepared MeMgI [prepared from Mg (0.24 g ,
0.01 mole) and CH3I (1.4-g,~~Ol-mole) in dry ether (20
mL) was added a solution of the ketone (6b or 6c, 0.01
mole) in dry ether (40 mL) at 20°C for 10 hr and gently
refluxed for 30 min. It was then cooled to 0 "C and
quenched with saturated solution of NHtCI followed by
extraction with ether provided the alcohol 7b and 7e in
90% yield. 7b: light yellow solid; m.p. 120-121 DC;
yield: 95%; IR (Nujol): 3400, 1470, 1370,780,610 em"
II IH NMR (200 MHz, CDCI3): 80.9 (d, J=7Hz, 6H),
1.6 (s, 6H), 1.95 (m, 1H), 2.2 (s, lH, -OH), 2.51 (d, J=
7.14 Hz, 2H), 7.l (d, J= 7.0 Hz, 2H), 7.45 (d, J= 7.15
Hz, 2H); 7e: Yellow solid, m.p. 91-96 DC; yield: 90%;
IR (Nujol: 3400, 1600, 1420, 1380, 1210 ern"; IH-NMR
(200 MHz, CDCI3): 8 1.52 (s, 6H), 1.95 (brs, lH), 3.95
(s, 3H), 7.2 (m, 2H), 7.85 (m, 2H), 7.95 (m, 2H).
Preparaion of olefins 2b and 2e. To an ice cooled
solution of the alcohol 7b or 7e (0.01 mole) in
dichloromethane (40 mL) was added pyridine (1.31 mL,
0.0\ 5 mole). To the above solution was added freshly
distilled POCI3 (1.0 mL, 0.01 mole) dropwise under
vigorous stirring. The reaction mixture was allowed to
stir at 25°C overnight. Usual work-up gave the olefin 2b
and 2e in good yield. 2b: yellow solid; m.p. 110°C;
yield: 90%; IR (Nujol): 1500, 1460, 1380, 1200, 810
cm': IH NMR (200 MHz, CDCh) : 80.9 (d, J= 8 Hz,
6H), 1.95 (m, IH), 2.1 (s, 3H), 2.5 (d, J= 8.1 Hz, 2H),
5.1 (d, J=8.0 Hz, lH), 5.4 (d, J= 7.99 Hz, IH), 7.1 (d,
J= 9.6 Hz, 2H), 7.45 (d, J= 9.6 Hz, 2H); 2e: yellow
solid; m.p. 109-110 DC; yield: 90%; IR (Nujol): 1610,
1500, 1450, 1390,1000,850 cm': IH NMR (200 MHz,
CDCI3): 8 2.2 (s, 3H), 3.95 (s, 3H), 5.2 (d, J= 8.0 Hz,
IH), 5.45 (d, J= 7.9 Hz, IH), 7.1 (m, 2H), 7.6-7.9 (m,
4H).
Preparation of the diols --3a, 3b and 3e. To a well
stirred mixture of K3Fe(CN)6 (6.6 g, 20 mmole), K2C03
(2.7 g, 20 mmole), H20 (20 mL), t-BuOH (20 mL),.
OS04 (0.1 mL, 0.4 M in toluene) and (DHQDh-PHAL
(25 mg, 0.1 mmole) at 0 °C was added MeS02NH2 (475
mg, 5 mmole) followed by 2a or 2b or 2e (5 mmole).
After 28 hr solid NaHS03 (5g) was added, the mixture
was stirred for i hr, extracted with EtOAc (3 x 25 mL)
and the organic layer was washed with dil. HCI (2M),
dried over anhyd. Na2S04 and concentrated under
reduced pressure to give 3a, 3b or 3c. Compound 3a :
colourless liquid yield : 82% IR (CHCI3): 3500-3350,
1440, 1360, 1210, 1025,860 cm": IH NMR (200 MHz,
CDCI3) 8 1.43 (s, 3H), 2.85 (br s, IH), 3.25 (s, 1H), 3.45
(m, IH), 3.53 (m, IH), 7.2-7.45 (m 5H); MS: mlz (% reI.
intensity) : 152 (M+, 90), 101 (40),78 (80); [a]o: -7.56
(c 2, EtOH); 3b: light yellow solid; m.p. 67-70 DC; yield:
85%; IR (Nujol): 3500-3450, 1520, 1470, 1370, 780 ern"
I; IH NMR (200 MHz, CDCI3): 80.9 (d, J= 7.1 Hz,6H),
1.5 (s, 3H), 1.8 (m, lH), 2.4 (brs, 1H), 2.51 (d, J= 7.0
Hz, 2H), 3.51 (d, J= 14 Hz, lH), 3.8 (d, J= 14 Hz, 1H),
7.1 (d, J= 9 Hz, 2H), 7.45 (d, J= 9.0 Hz, 2H); [a]o: -
7.01 (c 1.00. EtOH); 3e: yellow solid; m.p. 119-122 DC;
yield: 85%; IR (Nujol): 3500-3450, 1520, 1470, 1370,
780 cm": IH NMR (200 MHz, CDCI3): 8 1.6 (s, 3H),
2.2 (brs, IH), 3.7 (d, J= 7.6 Hz, lH), 3.8 (d, J= 7.6 Hz,
IH), 3.95 (s, 3H), 7.1 (d, J= 7.5 Hz, 2H), 7.5 (d, J= 7.6
Hz, lH), 7.7 (d, J= 7.6 Hz, 2H), 7.9 (d, J= 7.65 Hz, lH);
MS: mlz (% reI. intensity): 232 (M+, 30), 201 (100), 185
(80),171 (10), 157 (40); [a]o: -8.14 (c \.15, EtOH).
Preparation of alcohols 4a, 4b and 4e. In a two-necked
100 mL round bottom flask equipped with a magnetic
stirrer and reflux condenser, 3a or 3b or 3e (0.01 mole)
was dissolved in EtOH (25 ml.), 10% Pd-C (Aldrich, 50
mg), HCOONH4 (325 mg, 5 mmole) was added to this
solution and heated to reflux. After 6 hr, the suspension
was allowed to cool and then filtered through a pad of
Celite. The ethanolic solution was concentrated under
"reduced pressure to get the crude product with no traces
of starting material. Compound 4a: colourless liquid
yield: 65%; IR (CHCI3) 3400-3350, 1465, 1040, 1010,
780, 700 cm"; IH NMR (200 MHz, CDCh) : 8 1.24 (d,
3H, J=7.2Hz), 1.66 (br s, IH), 2.5-3.25 (m, IH), 3.58 (d,
2H, J=6.2Hz), 7.16 (m, 5H), [a]o : +3.54 (c 2 EtOH);
4b: white solid; m.p. 101-103 DC; yield: 65%; IR
(Nujol): 3400, 1610, 1580, 1410, 920, 810 cm': IH
NMR (200 MHz, CDCI3): 80.9 (d, J= 7.1 Hz, 6H), 1.2
(d, J= 7.0 Hz, 3H), 1.51 (brs, lH), 1.9 (m, lH), 2.45 (d,
J=6.9 Hz, 2H), 2.95 (m, IH), 3.7 (d, J= 6.9 Hz, 2H), 7.1
(m, 4H); MS: mlz (% reI. intensity): 192 (M+, 50), 136
(80),78 (90); [a]o: +8.4 (c LIS, EtOH); 4e: white solid;
m.p. 85-87 DC; yield: 75%; IR (Nujol): 3400, 1620,
1590, 1420, 980, 810 em": IH NMR (200 MHz,
CDCI3): () 0.9-1.0 (d, J= 3.5 Hz, 3H), 1.2 (brs, IH), 2.85
(m, IH), 3.4 (d, J= 3.4 Hz, 2H), 3.7 (s, 3H), 6.9-7.5 (rn,
6H); MS: mlz (% reI. intensity): 216 (M+, 50), 185
(100),170 (30),153 (20), 141 (20), II (15); [a]o: +2.52
(c \.10, EtOH).
Preparation of a-arylpropionic acids la, lb and Ic.
To a solution of the alcohol (4a or 4b or 4c, I mmole) in
acetone (4 mL) was treated drop wise with Jones'
reagent (3 mL) [prepared from 26 g of Cr(VI) oxide,
23 mL of concentrated H2S04 and 77 mL of water] at
o °C and stirred for 8 hr. Then the mixture was diluted
with water and extracted with chloroform (3 x 50 mL).
The organic phase was treated with saturated NaHC03
solution (2 x 50 mL). The combined aqueous extracts
were acidified to pH 1-2 with dil. H2S04 and extracted
with chloroform (5 x 50 ml.), After drying over anhyd.
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Na2S04, the solvent was removed under reduced
pressure and the residue was purified by flash column
chromatography (pet. ether: EtOAc; 8 : 2). Compound
la: low melting solid, yield 42%, IR (Nujol) 3400-
2800, 1710, 1605, 1510, 1455, 1075, 950, 865, 710
cm': IH NMR (200 MHz, CDCh): 0 1.52 (d, 3H, 1=7.2
Hz), 3.62 (q, 1H, 1=7.2 Hz), 7.2 (m,5H), 8.3 (br s, 1H);
MS (mlz) (reI. intensity): 150 (M+, 3), 105 (100), 91
(29),77.(72),63 (8); [a]o : + 48.4 (c 1, EtOH), lit.12
[a]o : +81.1 (c 1.0, EtOH); Ib: colourless.solid; m.p. 54-
56°C; yield: 40%; IR (CHCh): 2~10, 1700, 1600, 1280,
1000 em"; IH NMR (200 MHz, CDCh): 00.91 (d, 6H),
1.51 (d, 3H), 1.84 (m, 1H), 2.4 (brd, 2H), 3.5 (q, 1H),
6.9-7.4 (m, 4H); \3C NMR (50 MHz, CDCh) 0: 181.2,
140.7, 136.5, 129.3, 127.2,45.01,45.00,22.38, 18.06;
MS (mlz) (reI. intensity): 206 (M+, 45), 167 (100), 119
(55), 107 (52), 77 (12), 57 (10); [a]o : +38.0 (c 1.40,
CHCh), lit.13 [a]o : +60 (c 1.0, EtOH); Ic: colourless
solid; m.p. 154°C; yield: 35%; IR (CHCh): 2700,1701,
1640, 1320, 1100 em" ; IH NMR (200 MHz, CDCI3): 0
1.70 (d, 3H), 3.76 (q, 1H), 3.87 (s, 3H), 7.1-7.85 (m,
6H); MS (mlz) (reI. intensity): 230 (M+, 40), 185 (100),
170 (35), 153 (10), 141 (20), 115 (15); [a]o: +41.8 (c
1.55, CHCh), lit.14 [a]o: +65.5 (c 1.0, CHCh).
Preparation of 2-(2-fluoro-4-biphenyl)ethylpropio-
Date 9. A flame dried 100 mL RB flask fitted with a
reflux condenser and CaCh guard tube was charged with
racemic flurbiprofen (976 mg, 4 mmole) and dry ethanol
(20 mL) and cooled to ° "C in an ice bath. Freshly
distilled thionyl chloride (590 mg, 349 J,J.L,
5 mmole) was added dropwise and the mixture was
refluxed for 6 hr. The solvent was removed under
reduced pressure and the crude product was purified by
flash column chromatography using EtOAc : pet.ether (9
: 1) to yield a colourless thick liquid (lg). yield 94 %;
(Thick liquid); IR (Neat):2980, 1735, 1620, 1580, 1420,
1235,1180 em": IH NMR (200 MHz, CDCI3): 07.6-7.1
(m, 8H), 4.16 (q, 1 = 6.5 Hz, 2H), 3.75 (q, 1 = 8 Hz,
IH), 1.55 (d, 1=9.6 Hz, 3H), 1.76 (t, 1 = 8 Hz, 3H).
Preparation of 2-(2-fluoro-4-biphenyl)propanoll0. A
flame dried 100 mL RB flask fitted with a reflux
condenser was charged with LAH (75 mg, 2 mmole) and
dry ether (10 mL) and cooled in an ice bath under argon
atmosphere. The ester 9 (544 mg, 2 mmole) in dry ether
(2 mL) was added dropwise and the reaction mixture
was refluxed for 8 hr (monitored by TLC), cooled to rt
and was quenched with ethyl acetate. Extracted with
ether ( 3 x 15 mL) dried over anhyd. sodium sulfate and
evaporated to dryness. The crude product was purified
by flash column chromatography to afford the alcohol as
a white low melting solid (358 mg), yield 78 %; mp 56-
58°C; IR (Nujol): 3315, 2980, 1620, 1580, 1485, 1420,
1250 em"; IH NMR (200 MHz, CDCh): 0 7.65-7.25
(m, 6H), 7.15-7.0 (m, 2H), 3.75 (d, J = 8.5 Hz, 2H), 3.02
(m, lH), 1.7 (bs, OH), 1.35 (d, J = 10Hz, 3H).
Preparation of 2-(2-fluoro-4-biphenyl) p-toluene-
sulfonylpropionate 11. To a solution of the alcohol 10
(460 mg, 2 mmole) and Et3N (506 mg, 697 J,J.L,!5
mmole) in dry CH2Ch (2 mL) was added tosyl chloride
(401 mg, 2.1 mmole) in CH2Ch (2 mL) dropwise at °"C
under argon atmosphere. The reaction mixture was
stirred overnight at rt (monitored by TLC). The solvent
was evaporated to dryness and the crude solid was
purified by flash column chromatography to afford the
tosylate as a white solid (706 mg),yield 92 %; m.p. 108-
112°C; IR (Nujol): 2910, 1600, 1455, 1370, 1880, 970
em"; IH NMR (200 MHz, CDCh): 0 7.7 -7.25 (m,
10H), 7.05-6.85 (m, 2H), 4.1 (d, 1 = 8 Hz, 2H), 3.15 (m,
IH), 2.40 (s, 3H), 1.32 (d, 1 = 10Hz, 3H); MS (mlz, reI.
intensity, %) 384 (M+, 3), 272 (9), 230 (7), 212, (100),
199 (45),178 (32),155 (20),104 (38), 91 (35).
Preparation of 2-(2-fluoro-4-biphenyl)propane 12. A
flame dried 100 mL RB flask fitted with a reflux
condenser was charged with LAH (76 mg, 2 mmole) and
dry ether (8 mL) and cooled in an ice bath under argon
atmosphere. The tosylate 11 (768 mg, 2 mmole) in dry
ether (2 mL) was added dropwise and the reaction
mixture was refluxed for 8 hr (monitored by TLC),
cooled to rt , quenched with ethyl acetate, extracted with
ether (3 x 15 ml.), dried over anhyd. sodium sulfate and
evaporated to dryness. The crude product was purified
by flash column chromatography to afford the isopropyl
derivative as a colourless liquid (316 mg), yield 74 %;
oily liquid; IR (Neat): 3000, 2950, 1520, 1435, 1380,
1360, 1050 em"; IH NMR (200 MHz, CDCh): 0 7.6-
7.05 (m, 8H), 2.95 (m, IH), 0.98 (d, 1 = 7.5 Hz, 3H). 0.9
(d, 1 = 7 Hz, 3H); MS (mlz,rel. intensity, %) 214 (M+,
50),199 (90),181 (100), 170 (10),165 (26),152 (18).
Preparation of 2-bromo-2-(2-fluoro-4-biphenyl)-
propane 13. A flame- dried 50 mL RB flask fitted with a
reflux condenser was charged with the isopropyl
derivative 12 (428 mg, 2 mmole) and benzoyl peroxide
(10 mg) in dry CCLt (10mL) and was treated in portions
with NBS (445 mg, 2.5 mmole) at 0 DC. The reaction
mixture was stirred for 1 hr at rt and then refluxed for
2 hr. The reaction mixture was cooled and poured into
ice water, neutralized with aq. ammonia and extracted
with CH2Ch (3 x 15 mL). The combined organic layer
was washed with dil. HCI and dried over anhyd. sodium
sulfate. The solvent was evaporated I under reduced
pressure and the crude product was purified by flash
column chromatography using EtOAc : pet.ether (1 : 9)
as eluent to afford a light yellow solid (400 mg, 68%).
The product was directly used for dehydrobromination.
Preparation of 2-(2-fluoro-4-biphenyl)prop-l-ene 14.
A flame dried 50 mL 2-necked RB flask fitted with a
reflux condenser was charged with the bromocompound
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(588 mg, 2 mmole), LiBr (260 mg, 3 mmole), and
Li2C03 (222 mg, 3 rnmole) under argon atmosphere. The
reaction mixture was refluxed for 5 hr (monitored by
TLC), cooled to rt and poured into water, washed with
brine and extracted with ether (3 x 15 mL). The organic
layer was dried over anhyd.sodium sulfate, filtered and
evaporated to an yellow oil which was purified by flash
column chromatography (EtOAc : pet.ether, 0.5 : 9.5) to
furnish a colourless solid (322 mg, 76%), m.p. : 60-64
°C; IR (Nujol): 2990, 1610, 1500, 1450, 1395, 1050,
850, em": IH NMR (200 MHz, CDCh): 07.55-7.05 (m,
8H)~ 5.45 (d, J = 7.9 Hz, IH), 5.2 (d, J = 8 Hz, lH), 2.15
(s, 3H); MS (m/z, reI. intensity, %) : 212 (M+, 32), 201
(85),181 (100), 170 (14),167 (12),150 (15).
Preparation of 2-( 2-fluoro-4-biphenyl )-1, 2-dihy-
droxypropane 15. A double jacketed 100 mL flask was
charged with K3Fe(CN)6 (987 mg, 3 mmole) , K2C03
(414 mg, 3 mmole), (DHQDh-PHAL (20 mg, 0.025
mmole) in t-BuOH : H20 (1 : I, 10 mL) at 0 "c. A
solution of OS04 (20 IlL, 2.54 mg, 0.01 mmole; 0.5 M in
toluene) was added and stirred for 10 min. The olefin 14
(212 mg, I mmole) was added and the reaction mixture
was stirred for 30 hr quenched with sodium meta
bisulfite (1.04 mg, 6 mmole) and extracted with EtOAc
(3 x 20 mL), washed with brine (20 mL), dried over
anhyd. sodium sulfate, filtered and evaporated to get a
light yellow solid which was further purified by flash
column chromatography (EtOAc : pet. ether, 1 : 1 ) to
furnish a colourless solid (216 mg), yield 88 %; m.p. 96-
99°C; IR (Nujol):3350, 2975, 1585, 1435, 1220, 1030
cm': IH NMR (200 MHz, CDCl): 0 7.6-7.15 (m, 8H),
3.76 (d, J = 11.5 Hz, lH), 3.62 (d, J = 11.5 Hz, IH),
2.85 (bs, 20H), 1.5 (s, 3H); MS (rn/z, reI. intensity, %)
246 (M+, 1),231 (3),214 (20), 199 (57), 181 (54), 170
(37), 152 (50), 129 (49), 115 (20), 105 (100), 91 (90),
77 (96); [a]o25 - 6.6 (c, 1.5, EtOH).
Preparation of 2-(S)-2-(2-fluoro-4-biphenyl)propanol
16. A flame dried 100 mL RB flask fitted with a reflux
condenser was charged with the diol 15 (492 mg,
2 mmole), ammonium formate (378 mg, 6 mmole) and
10% Pd-C (25 mg) in dry ethanol (10 mL) under
nitrogen atmosphere. The reaction mixture was refluxed
for 16 hr (monitored by TLC). The solvent was
evaporated to dryness and the crude solid was washed
with water and extracted with ether (3 x 15 mL). After
removal of the ether under reduced pressure, the crude
product was purified by flash column chromatography
[EtOAc : pet.ether, (2 : 8)] to yield a low melting solid
(294 rng), yield 64 %; mp 55-58°C; IR (Nujol): 3310,
2930, 1620, 1580, 1480, 1415, 1250, 1030 cfu-I;
IH NMR (200 MHz, CDCh): 87.65-7.25 (m, 6H), 7.15-
7.0 (m, 2H), 3.75 (d, J = 8.5 Hz, 2H), 3.02 (m, lIt), 1.7
(bs, OH), 1.35 (d, J = 10Hz, 3H); MS (mlz, reI.
intensity, %): 230 (M+, 35), 212 (18), 199 (100), 178
(38), 170 (15), 165 (18), 152 (16), 133 (6), 115 (5), 91
(10),77 (8); [a]o25 +8.4 (c, 1.1, EtOH).
Preparation of 2-(S)-2-( 2-0uoro-4-biphenyl )pro-
pionic acid Id, A solution of the alcoho116 (460 mg, 2
mmole) in acetone (10 mL) was treated dropwise with
Jones' reagent (6 mL) [prepared from Cr(VI)oxide
(26g), con. H2S04 (23 mL) and water (77 mL)] at 0 °C
and stirred for 8h. The reaction mixture was diluted with
water (10 mL) and extracted with chloroform
(3 x 15 ml.). The organic layer was washed with
saturated NaHC03 solution (2 x 10 mL). The combined
aqueous extracts were acidified with dil. H2S04 and
extracted with chloroform (4 x 20 mL).The solvent was
removed under reduced pressure and the residue was
purified by flash column chromatography using EtOAc :
pet.ether (2 : 8) to furnish a colourless solid (352 mg),
yield 72%; mp 118 - 121°C; IR (Nujol) :3210, 1720,
1410, 1315 em": IH NMR (200 MHz, CDCl): 8 9.2
(b, IH), 7.5-7.15 (m, 8H), 3.8 (q, J = 8 Hz, IH), 1.6 (d,
J = 9.2 Hz, 3H); MS (mlz, reI. intensity, %): 244 (M+,
45), 199 (100), 183 (30), 178 (35), 170 (18), 159 (7),
152 (15), 133 (12), 99 (15), 85 (12),77 (18); [a]o25 +
25.4 (c, 1.8, EtOH); Litl5 : + 44.7 (c 1, EtOH).
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